<?xml version="1.0" encoding="UTF-8"?>
<p id="p0190">The COVID-19 infection seems to be unusual among patients with type 1 diabetes mellitus, although they are considered a fragile population. It has been hypothesized that the peculiar immune condition that leads to the destruction of the beta cells might play an important role 
 <xref rid="b0275" ref-type="bibr">[55]</xref>. On the other hand, the risk of increased frequency of severe ketoacidosis in new-onset type 1 diabetes due to delayed diagnosis - because of fear of contracting COVID-19 in a hospital setting, or inability to contact a medical provider for timely evaluation - should be considered 
 <xref rid="b0280" ref-type="bibr">[56]</xref>. Similarly, parents of patients with poor glycemic control requiring closer follow-up might postpone the appointments for the same reasons.
</p>
